Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Assessment of an ultra-sensitive IFNγ immunoassay prototype for latent tuberculosis diagnosis

Assessment of an ultra-sensitive IFNγ immunoassay prototype for latent tuberculosis diagnosis doi: 10.1684/ecn.2018.0417 Journal Identification = ECN Article Identification = 0417 Date: February 20, 2019 Time: 11:21 am 136 Eur. Cytokine Netw. Vol. 29 n 4, October-November-December 2018, 136-45 ORIGINAL ARTICLE Assessment of an ultra-sensitive IFN immunoassay prototype for latent tuberculosis diagnosis 1 1 2 2 2 Elyes Ben Salah , Karim Dorgham , Mylène Lesénéchal , Camille Pease , Laure Allard , Céline 2 1 1 1 Dragonetti , Guy Gorochov , Amélie Guihot , Delphine Sterlin Sorbonne université, Inserm, Centre d’immunologie et des maladies infectieuses (CIMI-Paris), AP-HP, groupement hospitalier de la Pitié-Salpêtrière, département d’immunologie, 75013 Paris, France bioMérieux, R&D Immunoassays, chemin de l’Orme, 69280 Marcy-l’Étoile, France Correspondence: Sorbonne université, Inserm, U1135, CIMI-Paris hôpital de la Pitié-Salpêtrière, bâtiment Cervi, 83, boulevard de l’Hopital, 75013 Paris, France. <karim.dorgham@inserm.fr> Accepted for publication October 11, 2018 To cite this article: Ben Salah E, Dorgham K, Lesénéchal M, Pease C, Allard L, Dragonetti C, Gorochov G, Guihot A, Sterlin D. Assessment of an ultra-sensitive IFN immunoassay prototype for latent tuberculosis diagnosis. Eur. Cytokine Netw. 2018; 29(4): 136-45 doi:10.1684/ecn.2018.0417 ABSTRACT. Worldwide there are about 1.7 billion individuals with latent tuberculosis infection (LTBI) and only 5% to 15% will develop active tuberculosis (TB). It is http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Cytokine Network Springer Journals

Assessment of an ultra-sensitive IFNγ immunoassay prototype for latent tuberculosis diagnosis

Loading next page...
 
/lp/springer-journals/assessment-of-an-ultra-sensitive-ifn-immunoassay-prototype-for-latent-zGXV5dlWpT
ISSN
1148-5493
eISSN
1148-5493
DOI
10.1684/ecn.2018.0417
Publisher site
See Article on Publisher Site

Abstract

doi: 10.1684/ecn.2018.0417 Journal Identification = ECN Article Identification = 0417 Date: February 20, 2019 Time: 11:21 am 136 Eur. Cytokine Netw. Vol. 29 n 4, October-November-December 2018, 136-45 ORIGINAL ARTICLE Assessment of an ultra-sensitive IFN immunoassay prototype for latent tuberculosis diagnosis 1 1 2 2 2 Elyes Ben Salah , Karim Dorgham , Mylène Lesénéchal , Camille Pease , Laure Allard , Céline 2 1 1 1 Dragonetti , Guy Gorochov , Amélie Guihot , Delphine Sterlin Sorbonne université, Inserm, Centre d’immunologie et des maladies infectieuses (CIMI-Paris), AP-HP, groupement hospitalier de la Pitié-Salpêtrière, département d’immunologie, 75013 Paris, France bioMérieux, R&D Immunoassays, chemin de l’Orme, 69280 Marcy-l’Étoile, France Correspondence: Sorbonne université, Inserm, U1135, CIMI-Paris hôpital de la Pitié-Salpêtrière, bâtiment Cervi, 83, boulevard de l’Hopital, 75013 Paris, France. <karim.dorgham@inserm.fr> Accepted for publication October 11, 2018 To cite this article: Ben Salah E, Dorgham K, Lesénéchal M, Pease C, Allard L, Dragonetti C, Gorochov G, Guihot A, Sterlin D. Assessment of an ultra-sensitive IFN immunoassay prototype for latent tuberculosis diagnosis. Eur. Cytokine Netw. 2018; 29(4): 136-45 doi:10.1684/ecn.2018.0417 ABSTRACT. Worldwide there are about 1.7 billion individuals with latent tuberculosis infection (LTBI) and only 5% to 15% will develop active tuberculosis (TB). It is

Journal

European Cytokine NetworkSpringer Journals

Published: Oct 1, 2018

There are no references for this article.